BridgeBio: Buy Rating Backed by Attruby’s Multi-Billion Peak Sales Potential and De-Risked Launch Portfolio
at www.tipranks.com (Mon, 3-Aug 9:45 AM)
Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), BridgeBio Pharma (BBIO) and Universal Health (UHS)
at www.tipranks.com (Mon, 3-Aug 7:20 AM)
